This cooperation aims to expedite access to advanced medicines and vaccines developed by GSK, particularly by bringing to ...

The Global Fund has welcomed a £6 million joint investment from GSK and ViiV Healthcare to strengthen community-led responses ...

GSK now owns the global development and commercialisation rights to Empirico's COPD-targeting (siRNA) oligonucleotide, ...

British pharmaceutical group GSK on Wednesday raised its full-year outlook after strong sales growth in its third quarter, ...

With the FTSE 100 hitting new highs last month, Mark Hartley considers where global stock markets may be heading next – and how UK investors can prepare. The post The UK stock market hits new highs – ...

The UK's FTSE 100 index reached a new high, driven by positive earnings forecasts from GSK and Next. GSK's stock surged, ...

Next set to turn heads with special dividend, upbeat Q3 numbers from GSK bolster FY outlook,, WH Smith FY numbers to follow ...

GSK has boosted its pipeline of antibody-drug conjugates for cancer, licensing a prostate cancer candidate from Syndivia in a ...

GSK Plc (NYSE:GSK) has received UK approval for its oral antibiotic Blujepa (gepotidacin), designed to treat uncomplicated urinary tract infections. According to the UK medicines regulator, UTIs ...

* Cap at 34.8 mln doses, saving third of original order * Govt says no cancellation fee paid, details confidential * GSK says will work with governments as needs change (Adds quotes, details, ...

We recently published a list of the 11 Best Undervalued UK Stocks to Buy Right Now. In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against other best undervalued UK ...